After 20 years with no new Alzheimer’s disease drugs in the UK, we now have two potential new drugs in just twelve months â and for the first time, drugs that seem to slow the progression of disease.
We get calls every day to our support line asking for help on how to make sense of a diagnosis and deal with the seismic shift that conditions like Alzheimer’s disease inevitably bring to everyday life.
For many, taking part in research can be part of the answer.
Being involved in a trial often helps people living with dementia gain a better understanding of their condition and also allows them to have their health monitored more closely.
Not only can trials help the individual, they’re also vital to push research forward. Now we will find out the results from a trial of a potential drug called donanema.